Join to view full profile
UF Health Shands Children's Hospital1600 SW Archer RdGainesville, FL 32610
Dr. Jacobsen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Laura Jacobsen is a pediatric endocrinologist in Gainesville, FL and is affiliated with UF Health Shands Hospital.
Education & Training
University of FloridaFellowship, Pediatric Endocrinology, 2015 - 2018
University of North Carolina HospitalsResidency, Pediatrics, 2012 - 2015- University of Florida College of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2015 - 2027
NC State Medical License 2012 - 2015
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- A Pilot Randomized Controlled Clinical Trial to Improve Adherence Barriers for Adolescents with Type 1 Diabetes.Avani C Modi, Constance A Mara, Holly O'Donnell, Matthew Schmidt, Jessica C Kichler
The Journal of Pediatrics. 2026-08-01 - Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.Laura M Jacobsen, Dave Cuthbertson, Jamie Felton, Jennifer L Sherr, Kimber M Simmons
Diabetes Care. 2026-08-01 - Review of Type 1 Diabetes-Reply.Desmond A Schatz, Laura M Jacobsen
JAMA. 2026-07-28
Press Mentions
UF Health-Led Guidelines Call for Widespread Type 1 Diabetes Screening in ChildrenJanuary 30th, 2025- Omnipod 5 ‘Artificial Pancreas’ Shows Benefit in Type 1 DiabetesJune 27th, 2021
- Omnipod 5 ‘Artificial Pancreas’ Shows Benefit in Type 1 DiabetesJune 27th, 2021
Grant Support
- Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetesUNIVERSITY OF FLORIDA2025–2030
- Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 DiabetesUNIVERSITY OF FLORIDA2021–2026
- Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 DiabetesUNIVERSITY OF FLORIDA2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
